Skip to main content
Top
Published in: Endocrine 1/2011

01-08-2011 | Original Article

The prevalence of adrenal incidentaloma in routine clinical practice

Authors: Colin Davenport, Aaron Liew, Bryan Doherty, Htet Htet N. Win, Hafiza Misran, Sarah Hanna, David Kealy, Fatima Al-Nooh, Amar Agha, Christopher J. Thompson, Michael Lee, Diarmuid Smith

Published in: Endocrine | Issue 1/2011

Login to get access

Abstract

The prevalence of adrenal incidentaloma (AI) on computed tomography (CT) in the general population has been reported to be as high as 4.2%. However, many of the previous studies in this field utilised a prospective approach with analysis of CT scans performed by one or more radiologists with a specialist interest in adrenal tumours and a specific focus on identifying the presence of an adrenal mass. A typical radiology department, with a focus on the patient’s presenting complaint as opposed to the adrenal gland, may not be expected to diagnose as many adrenal incidentalomas as would be identified in a dedicated research protocol. We hypothesised that the number of AI reported in routine clinical practice is significantly lower than the published figures would suggest. We retrospectively reviewed the reports of all CT thorax and abdomen scans performed in our hospital over a 2 year period. 3,099 patients underwent imaging, with 3,705 scans performed. The median age was 63 years (range 18–98). Thirty-seven true AI were diagnosed during the time period studied. Twenty-two were diagnosed by CT abdomen (22/2,227) and 12 by CT thorax (12/1,478), a prevalence of 0.98 and 0.81% with CT abdomen and thorax, respectively, for AI in routine clinical practice.
Literature
1.
go back to reference W.F. Young Jr, Clinical practice. The incidentally discovered adrenal mass. N. Engl. J. Med. 356(6), 601–610 (2007)PubMedCrossRef W.F. Young Jr, Clinical practice. The incidentally discovered adrenal mass. N. Engl. J. Med. 356(6), 601–610 (2007)PubMedCrossRef
2.
go back to reference NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens. State Sci. Statements 2002 Feb 4-6;19(2):1–25 NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens. State Sci. Statements 2002 Feb 4-6;19(2):1–25
3.
go back to reference A. Comlekci, S. Yener, S. Ertilav, M. Secil, B. Akinci, T. Demir, L. Kebapcilar, F. Bayraktar, S. Yesil, S. Eraslan, Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 37(1), 40–46 (2010)PubMedCrossRef A. Comlekci, S. Yener, S. Ertilav, M. Secil, B. Akinci, T. Demir, L. Kebapcilar, F. Bayraktar, S. Yesil, S. Eraslan, Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 37(1), 40–46 (2010)PubMedCrossRef
4.
go back to reference S. Bovio, A. Cataldi, G. Reimondo, P. Sperone, S. Novello, A. Berruti, P. Borasio, C. Fava, L. Dogliotti, G.V. Scagliotti, A. Angeli, M. Terzolo, Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J. Endocrinol. Invest. 29(4), 298–302 (2006)PubMed S. Bovio, A. Cataldi, G. Reimondo, P. Sperone, S. Novello, A. Berruti, P. Borasio, C. Fava, L. Dogliotti, G.V. Scagliotti, A. Angeli, M. Terzolo, Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J. Endocrinol. Invest. 29(4), 298–302 (2006)PubMed
5.
go back to reference E.V. Ferreira, M.A. Czepielewski, C.S. Faccin, M.C. Accordi, A.P. Furtado, Prevalence of adrenal incidentaloma at computed tomography (chest and abdominal) in a general hospital in Brazil. Arq. Bras. Endocrinol. Metabol. 49(5), 769–775 (2005)PubMedCrossRef E.V. Ferreira, M.A. Czepielewski, C.S. Faccin, M.C. Accordi, A.P. Furtado, Prevalence of adrenal incidentaloma at computed tomography (chest and abdominal) in a general hospital in Brazil. Arq. Bras. Endocrinol. Metabol. 49(5), 769–775 (2005)PubMedCrossRef
6.
go back to reference M.F. Herrera, C.S. Grant, J.A. van Heerden, P.F. Sheedy, D.M. Ilstrup, Incidentally discovered adrenal tumors: an institutional perspective. Surgery 110(6), 1014–1021 (1991)PubMed M.F. Herrera, C.S. Grant, J.A. van Heerden, P.F. Sheedy, D.M. Ilstrup, Incidentally discovered adrenal tumors: an institutional perspective. Surgery 110(6), 1014–1021 (1991)PubMed
7.
go back to reference L.S. Eldeiry, J.R. Garber, Adrenal incidentalomas, 2003 to 2005: experience after publication of the National Institutes of Health consensus statement. Endocr Pract 14(3), 279–284 (2008)PubMed L.S. Eldeiry, J.R. Garber, Adrenal incidentalomas, 2003 to 2005: experience after publication of the National Institutes of Health consensus statement. Endocr Pract 14(3), 279–284 (2008)PubMed
8.
go back to reference J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith, The incidental adrenal mass on CT: prevalence of adrenal disease in 1, 049 consecutive adrenal masses in patients with no known malignancy. AJR Am. J. Roentgenol. 190(5), 1163–1168 (2008)PubMedCrossRef J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith, The incidental adrenal mass on CT: prevalence of adrenal disease in 1, 049 consecutive adrenal masses in patients with no known malignancy. AJR Am. J. Roentgenol. 190(5), 1163–1168 (2008)PubMedCrossRef
9.
go back to reference Y. Erbil, N. Ozbey, U. Barbaros, H.R. Unalp, A. Salmaslioglu, S. Ozarmagan, Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality? World J. Surg. 33(10), 2099–2105 (2009)PubMedCrossRef Y. Erbil, N. Ozbey, U. Barbaros, H.R. Unalp, A. Salmaslioglu, S. Ozarmagan, Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality? World J. Surg. 33(10), 2099–2105 (2009)PubMedCrossRef
10.
go back to reference M. Terzolo, A. Pia, A. Alì, G. Osella, G. Reimondo, S. Bovio, F. Daffara, M. Procopio, P. Paccotti, G. Borretta, A. Angeli, Adrenal incidentaloma: a new cause of the metabolic syndrome? J. Clin. Endocrinol. Metab. 87(3), 998–1003 (2002)PubMedCrossRef M. Terzolo, A. Pia, A. Alì, G. Osella, G. Reimondo, S. Bovio, F. Daffara, M. Procopio, P. Paccotti, G. Borretta, A. Angeli, Adrenal incidentaloma: a new cause of the metabolic syndrome? J. Clin. Endocrinol. Metab. 87(3), 998–1003 (2002)PubMedCrossRef
11.
go back to reference S. Midorikawa, H. Sanada, S. Hashimoto, T. Suzuki, T. Watanabe, The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin. Endocrinol. (Oxf.) 54(6), 797–804 (2001)CrossRef S. Midorikawa, H. Sanada, S. Hashimoto, T. Suzuki, T. Watanabe, The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin. Endocrinol. (Oxf.) 54(6), 797–804 (2001)CrossRef
Metadata
Title
The prevalence of adrenal incidentaloma in routine clinical practice
Authors
Colin Davenport
Aaron Liew
Bryan Doherty
Htet Htet N. Win
Hafiza Misran
Sarah Hanna
David Kealy
Fatima Al-Nooh
Amar Agha
Christopher J. Thompson
Michael Lee
Diarmuid Smith
Publication date
01-08-2011
Publisher
Springer US
Published in
Endocrine / Issue 1/2011
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9445-6

Other articles of this Issue 1/2011

Endocrine 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine